Mydekla is an antiviral medicine used in combination therapy for chronic Hepatitis C. It works by blocking viral replication, helping achieve effective viral clearance.
| Generic Name | Daclatasvir |
| Manufacturer | MYLAN |
| Packing | 28 Tablets |
| Prescribed For | Chronic Hepatitis C |
| Expiry | December 2027 |
Natdac contains Daclatasvir 60mg, a direct-acting antiviral medication used in combination with other drugs for the treatment of chronic Hepatitis C virus (HCV) infection.
| Composition | Daclatasvir |
| Manufacturer | Natco Pharma Ltd |
| Packing | 28 Tablets |
| Prescribed For | Hepatitis C Virus |
| Expiry | December 2027 |
| Composition | Daclatasvir |
| Manufacturer | Hetero Drugs Ltd |
| Packing | 28 Tablets |
| Prescribed For | Hepatitis C Virus |
| Expiry | December 2027 |
Dacikast 60mg contains Daclatasvir Dihydrochloride, an antiviral medication used in the treatment of chronic Hepatitis C virus (HCV) infection.
| Composition | Daclatasvir |
| Manufacturer | Aprazer Healthcare Pvt ltd |
| Packing | 28 Tablets |
| Prescribed For | Hepatitis C Virus |
| Expiry | December 2027 |
